Lung Biotechnology PBC   Report issue

For profit Phase 2 Phase 3
Founded: Silver Spring MD United States (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2008
NCT00703339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Lung Biotechnology PBC